Case report of a fatal rectal haemorrhage in a person with severe haemophilia A receiving emicizumab and high-dose bypassing agents in the HAVEN 1 study

Haemophilia. 2020 Nov;26(6):e340-e342. doi: 10.1111/hae.14110. Epub 2020 Jul 22.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Bispecific / drug effects*
  • Antibodies, Monoclonal, Humanized / drug effects*
  • Hemophilia A / complications
  • Hemorrhage / etiology*
  • Hemorrhage / pathology
  • Humans
  • Male
  • Rectum / pathology*

Substances

  • Antibodies, Bispecific
  • Antibodies, Monoclonal, Humanized
  • emicizumab

Grants and funding